Literature DB >> 7744450

Preventive strategies for pediatric AIDS.

S Lal1, D Sengupta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7744450     DOI: 10.1007/BF02751709

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  6 in total

1.  Predicting the progression to AIDS.

Authors:  M A Polis; H Masur
Journal:  Am J Med       Date:  1990-12       Impact factor: 4.965

2.  A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research.

Authors:  R R Redfield; D L Birx; N Ketter; E Tramont; V Polonis; C Davis; J F Brundage; G Smith; S Johnson; A Fowler
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

3.  High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.

Authors:  M S Saag; M J Crain; W D Decker; S Campbell-Hill; S Robinson; W E Brown; M Leuther; R J Whitley; B H Hahn; G M Shaw
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

4.  HIV-specific cytotoxic T lymphocytes in seropositive individuals.

Authors:  B D Walker; S Chakrabarti; B Moss; T J Paradis; T Flynn; A G Durno; R S Blumberg; J C Kaplan; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

5.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.

Authors:  E S Daar; T Moudgil; R D Meyer; D D Ho
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

6.  A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group.

Authors:  S Blanche; C Rouzioux; M L Moscato; F Veber; M J Mayaux; C Jacomet; J Tricoire; A Deville; M Vial; G Firtion
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.